Use of a pandemic H1N1 strain with updated haemagglutinin and neuraminidase results in increased nasopharyngeal shedding and improved immunogenicity to Russian-backbone live attenuated influenza vaccine among children aged 2 – 4 years old: an open-label, prospective, observational, phase 4 study in The Gambia
Published in 2019 by
B. B. Lindsey,
Lindsey Bb,
Y. J. Jagne,
T. I. de Silva,
Jagne Yj,
E. P. Armitage,
Armitage Ep,
A. Singanayagam,
H. J. Sallah,
Sallah Hj,
S. Drammeh,
N. I. Mohammed,
E. Senghore,
D. Jeffries 
,
Mohammed Ni
and other authors.
,
Mohammed Ni
and other authors.
